Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login
Users Online :664
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission
     Next Issue
  Previous Issue

 


Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
   Table of Contents
Coverpage
March 2022
Volume 59 | Issue 5 (Supplement)
Page Nos. 1-174

Online since Thursday, March 24, 2022

Accessed 13,652 times.

PDF access policy
Journal allows immediate open access to content in HTML + PDF

EPub access policy
Full text in EPub is free except for the current issue. Access to the latest issue is reserved only for the paid subscribers.
View as eBookView issue as eBook
Access StatisticsIssue statistics
RSS FeedRSS
Show all abstracts  Show selected abstracts  Export selected to  Add to my list
ORIGINAL ARTICLES  

Safety of osimertinib in adult patients with metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: Results from a Phase IV study in India p. 1
Prabhat S Malik, Vanita Noronha, Deepak Dabkara, Vamshi K Maddu, Senthil Rajappa, Sewanti Limaye, Ullas Batra
DOI:10.4103/ijc.ijc_1374_21  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

CONCORDANCE: A real-world evidence study to evaluate the concordance of detecting epidermal growth factor receptor (EGFR) mutation by circulating tumor DNA* versus tissue biopsy in patients with metastatic non-small cell lung cancer p. 11
Kumar Prabhash, Bivas Biswas, Sachin Khurana, Ullas Batra, Ghanashyam Biswas, Suresh Hariram Advani, Prabrajya N Mohapatra, Senthil Rajappa, Ajay Sharma, Shekhar Patil, Palanki Satya Dattatreya, Rakesh Roy, Sachin Almel, Gautam Goyal, Narayanankutty Warrier
DOI:10.4103/ijc.ijc_438_21  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta
REVIEW ARTICLES Top

Expert survey on management of prostate cancer in India: Real-world insights into practice patterns p. 19
Ganesh Bakshi, Hemant Tongaonkar, Sanjai Addla, Santosh Menon, Aditya Pradhan, Abhay Kumar, Abhijit Bapat, Adwaita Gore, Amit Joshi, Anand Raja, Anil Bradoo, Anita Ramesh, Anup Kumar, Archi Agrawal, Asawari Ambekar, Ashish Joshi, Ashish Singh, Bhupendra Pal Singh, Deepak Dabkara, Dhiraj Khadakban, Gagan Gautam, Gagan Prakash, Harvinder Singh Pahwa, Hemant Kumar Goel, Jagdeesh Kulkarni, Jeeban Jyoti Mishra, Kaushal Patel, Mahendra Pal, Percy Jal Chibber, Priya Tiwari, Radheshyam Naik, SK Raghunath, Rahul Krishnatry, Rajendra Shimpi, Rakesh Sharma, Rakesh Taran, Sameer Trivedi, Sanjay Nabar, Sanjoy Surekha, Satish Kumar, Satyakam Krishna Sawaimoon, Shailesh Raina, Srivatsa Narasimha, Suresh Advani, Syed Mohammed Ghouse, Vamshi Krishna Muddu, Vashishth Maniar, Vivek Venkat, Vedang Murthy
DOI:10.4103/ijc.ijc_1145_21  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

Relevance of multi-disciplinary team approach in diagnosis and management of Stage III NSCLC p. 46
Ullas Batra, Anusheel Munshi, Vedant Kabra, Gagandeep Momi
DOI:10.4103/ijc.IJC_51_21  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

BRCA mutations: Implications of genetic testing in ovarian cancer p. 56
Vineet Talwar, Amit Rauthan
DOI:10.4103/ijc.IJC_1394_20  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

Role of immunotherapy in metastatic EGFRm NSCLC: Is it relevant? p. 68
Boman Dhabhar, Tarini P Sahoo, JK Akshay
DOI:10.4103/ijc.IJC_49_21  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

Ideal sequencing in Stage IV epidermal growth factor receptor mutant Non–Small-Cell Lung Cancer p. 80
Meenu Walia, Manish K Singhal, Mangesh S Kamle
DOI:10.4103/ijc.IJC_50_21  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

Evolving trends in lung cancer: Epidemiology, diagnosis, and management p. 90
Ramakant Deshpand, Manish Chandra, Amit Rauthan
DOI:10.4103/ijc.IJC_52_21  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

Significance of emerging clinical oncology endpoints in support of overall survival p. 106
Shekar Patil, Vijay Agarwal, HS Drupad
DOI:10.4103/ijc.IJC_1417_20  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

A review on mechanisms of resistance to PARP inhibitors p. 119
Chirag Desai, Anand Pathak, Sewanti Limaye, Vashishth Maniar, Archita Joshi
DOI:10.4103/ijc.IJC_53_21  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

Management of human epidermal growth factor receptor 2–negative metastatic breast cancer: Role of poly adenosine diphosphate (ADP-ribose) polymerase inhibitors p. 130
Ashok Kumar Vaid, Chetan Deshmukh, Nitesh Rohatgi, Joydeep Ghosh
DOI:10.4103/ijc.IJC_30_21  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

Gonadotropin-releasing hormone agonists in prostate cancer: A comparative review of efficacy and safety p. 142
T Raja, Rahul Sud, Sanjai Addla, Kalyan K Sarkar, PS Sridhar, Vikas Talreja, Minish Jain, Ketaki Patil
DOI:10.4103/ijc.IJC_65_21  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

A review of clinical evidence to assess differences in efficacy and safety of luteinizing hormone–releasing hormone (LHRH) agonist (goserelin) and LHRH antagonist (degarelix) p. 160
Ankur Bahl, Senthil Rajappa, Sudhir Rawal, Ganesh Bakshi, Vedang Murthy, Ketaki Patil
DOI:10.4103/ijc.IJC_1415_20  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta
  Site Map | What's new | Copyright and Disclaimer | Privacy Notice
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow